| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ZAFGEN INC COM | 40,000 | 1,278,000 | 0.50% | ||
| 52 | ALNYLAM PHARMACEUTICALS INC | 15,000 | 1,205,000 | 0.47% | ||
| 53 | Esperion Therapeutics Inc | 50,000 | 1,180,000 | 0.46% | ||
| 54 | ESPERION THERAPEUTICS INC | 50,000 | 1,180,000 | 0.46% | Call | |
| 55 | GENESIS HEALTHCARE INC | 180,000 | 1,103,000 | 0.43% | ||
| 56 | IGNYTA INC COM | 125,000 | 1,098,000 | 0.43% | ||
| 57 | AERIE PHARMACEUTICALS INC COM | 60,015 | 1,065,000 | 0.42% | ||
| 58 | ARIAD PHARMACEUTICALS ORD (NMS) | 125,000 | 1,058,000 | 0.42% | ||
| 59 | OCULAR THERAPEUTIX INC | 75,000 | 1,055,000 | 0.41% | ||
| 60 | REVANCE THERAPEUTICS INC COM | 35,000 | 1,042,000 | 0.41% | ||
| 61 | IMMUNE DESIGN CORP | 75,000 | 915,000 | 0.36% | ||
| 62 | SUPERNUS PHARMACEUTICALS INC | 65,000 | 912,000 | 0.36% | Call | |
| 63 | SCYNEXIS INC | 125,000 | 910,000 | 0.36% | ||
| 64 | ADAPTIMMUNE THERAPEUTICS PLC | 75,000 | 898,000 | 0.35% | ||
| 65 | DICERNA PHARMACEUTICALS INC | 100,000 | 821,000 | 0.32% | ||
| 66 | Arrowhead Pharma Inc | 125,000 | 720,000 | 0.28% | ||
| 67 | NEVRO CORP | 15,000 | 696,000 | 0.27% | Call | |
| 68 | Marinus Pharmaceuticals Inc | 75,000 | 626,000 | 0.25% | ||
| 69 | MEI PHARMA INC | 325,000 | 510,000 | 0.20% | ||
| 70 | CYMABAY THERAPEUTICS INC | 250,000 | 485,000 | 0.19% | ||
| 71 | PEREGRINE PHARMACEUTICALS IN | 350,000 | 357,000 | 0.14% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-15-000013, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
